MetaCap

IRulya Therapeutics Statistics

NASDAQ: IRLAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

39.88-0.06 (-0.15%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

IRulya Therapeutics by the numbers

IRulya Therapeutics has a market capitalization of $432.4 million based on 10.84M shares outstanding. With trailing EPS of $-162.79, IRulya Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 22.6% above its 50-day average and 46.5% above its 200-day average.

Average daily trading volume is 63.03K shares, or about $2.5 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

IRLA valuation vs. peer median

IRLA compared with the median of 8 peer companies
MetricIRLAPeer medianDifference
Market cap$432.36M$438.68M-1%
Avg. volume63.03K1.33M-95%

Peer median across 8 companies: PROK, TECX, TVGN, FENC, CADL, RGNX, SANA, DNA.

Valuation

Price and trading

Previous close
39.94
Open
39.94
Day range
38.92 – 42.00
52-week range
15.10 – 910.00
Beta
—
Volume
200.56K

Dividends and events

Annual dividend
None
Next earnings date
Nov 13, 2026

Additional statistics

Market Cap
432.36M
Forward Pe
-8.56
Eps
-162.79
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
910.00
Week52 Low
15.10
Avg Volume
63,028.00
Shares Outstanding
10.84M
Ma50
32.52
Ma200
27.23
Earnings Date
Nov 13, 2026
Pct From52w High
-95.62%
Pct From52w Low
164.11%

Related